Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress

Keyphrases

• Cardiovascular Prevention 100%
• European Society of Cardiology 100%
• Prevention Study 100%
• Preventive Strategies 50%
• Cardiovascular Disease 50%
• Treatment Strategy 50%
• Cardiovascular Mortality 50%
• Aspirin 50%
• Heart Failure 50%
• Acute Myocardial Infarction 50%
• Secondary Prevention 50%
• Cardiovascular Events 50%
• Fourier 50%
• Cardiology 50%
• Image-based 50%
• Acute Coronary Syndrome 50%
• Influenza Vaccine 50%
• Stress Testing 50%
• Troponin 50%
• Environmental Risk Factors 50%
• Omega-3 Fatty Acids 50%
• Death Events 50%
• Comprehensive Imaging 50%
• Neurohormonal Blockade 50%
• Cardiovascular Screening 50%
• Empagliflozin 50%
• Anthracycline Toxicity 50%
• Global Strategy 50%
• Evolocumab 50%
• Air Temperature Effect 50%
• ESC Congress 50%
• Icosapent Ethyl 50%
• Cardiovascular Polypill 50%
• REDUCE-IT 50%
• High-risk PCI 50%
• Focused Review 50%
• ST-elevation MI 50%

Medicine and Dentistry

• Cardiology 100%
• Cardiovascular Disease Prevention 100%
• Cardiovascular System 100%
• Percutaneous Coronary Intervention 66%
• Cardiovascular Disease 33%
• Myocardial Infarction 33%
• Congestive Heart Failure 33%
• Secondary Prevention 33%
• Acute Heart Infarction 33%
• Cardiovascular Mortality 33%
• Acetylsalicylic Acid 33%
• Troponin 33%
• Influenza Vaccine 33%
• Vasoactive Intestinal Polypeptide 33%
• ST Segment Elevation Myocardial Infarction 33%
• Omega-3 Fatty Acid 33%
• Polypill 33%
• Empagliflozin 33%
• Evolocumab 33%
• Anthracycline Toxicity 33%
• Icosapentaenoic Acid Ethyl Ester 33%
• Temperature Effect 33%
• Acute Coronary Syndrome 33%
• Arteriosclerotic Heart Disease 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 100%
• Acetylsalicylic Acid 50%
• Acute Heart Infarction 50%
• Congestive Heart Failure 50%
• Omega-3 Fatty Acid 50%
• Cardiovascular Mortality 50%
• Acute Coronary Syndrome 50%
• Coronary Artery Atherosclerosis 50%
• Troponin 50%
• Live Attenuated Influenza Vaccine 50%
• ST Segment Elevation Myocardial Infarction 50%
• Vasoactive Intestinal Polypeptide 50%
• Temperature Effect 50%
• Empagliflozin 50%
• Anthracycline Toxicity 50%
• Evolocumab 50%
• Icosapentaenoic Acid Ethyl Ester 50%